{
  "purpose": "2009 tables, listing & figures",
  "libname": [{ "libname": "adam2", "path": "/adam2" }],
  "filename": [{ "filename": "stuff3", "path": "/stuff3" }],
  "outputs": [
    {
      "section": "General characteristics",
      "type": "Table",
      "num": "T14.1.1.1",
      "no": "TABLE 14.1.1.1",
      "title": "ANALYSIS SETS",
      "population": "ALL SCREENED PARTICIPANTS          ",
      "program": "t_anaset",
      "programmer": "Phil Mason",
      "comments": "Phil is working on this table. He hasn't started yet, but he will soon. Oh no, he is going away for a snooker holiday to the Isle of Wight. When he returns he will play darts with the local pub team. He will then start on this table if he is not too tired.",
      "qc": 1,
      "qc_comments": "passed with flying colors",
      "qc_status": "Not yet started",
      "priority": 1,
      "topline": true
    },
    {
      "section": "General characteristics",
      "type": "Table",
      "num": "T14.1.1.2",
      "no": "TABLE 14.1.1.2",
      "title": "SUMMARY OF DISPOSITION",
      "population": "ALL SCREENED PARTICIPANTS          ",
      "program": "t_disp",
      "qc": 0,
      "qc_comments": "errors found and here are some long comments to explain what happened.",
      "qc_status": "Not needed",
      "priority": 2
    },
    {
      "section": "General characteristics",
      "type": "Table",
      "num": "T14.1.1.6",
      "no": "TABLE 14.1.1.6",
      "title": "TREATMENT DISCONTINUATION",
      "population": "SAFETY",
      "program": "t_tdisc",
      "qc_status": "In progress",
      "priority": 3
    },
    {
      "section": "General characteristics",
      "type": "Table",
      "num": "T14.1.2.1",
      "no": "TABLE 14.1.2.1",
      "title": "DEMOGRAPHIC DATA",
      "population": "SAFETY",
      "program": "t_demog1",
      "qc_status": "Complete"
    },
    {
      "section": "General characteristics",
      "type": "Table",
      "num": "T14.1.2.2",
      "no": "TABLE 14.1.2.2",
      "title": "BASELINE DISEASE CHARACTERISTICS",
      "population": "SAFETY",
      "program": "t_demog2"
    },
    {
      "section": "General characteristics",
      "type": "Table",
      "num": "T14.1.2.8",
      "no": "TABLE 14.1.2.8",
      "title": "RESCUE THERAPIES BY ATC CLASS (LEVEL 1 AND 3) AND GENERIC TERM",
      "population": "SAFETY",
      "program": "t_cm_rescue"
    },
    {
      "section": "General characteristics",
      "type": "Table",
      "num": "T14.1.2.9",
      "no": "TABLE 14.1.2.9",
      "title": "INTERCURRENT EVENTS OF DISALLOWED THERAPIES THAT MAY INFLUENCE EFFICACY BY ATC CLASS (LEVEL 1 AND 3) AND GENERIC TERM",
      "population": "SAFETY",
      "program": "t_cm_inter"
    },
    {
      "section": "General characteristics",
      "type": "Table",
      "num": "T14.1.2.10",
      "no": "TABLE 14.1.2.10",
      "title": "CONCOMITANT ORAL CORTICOSTEROID ADMINISTRATION FOR BP BY ATC CLASS (LEVEL 1 AND 3) AND GENERIC TERM",
      "population": "SAFETY",
      "program": "t_cm_ocs"
    },
    {
      "section": "General characteristics",
      "type": "Table",
      "num": "T14.1.2.11",
      "no": "TABLE 14.1.2.11",
      "title": "IMP ADMINISTRATION",
      "population": "SAFETY",
      "program": "t_impad"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.1.2.1",
      "no": "TABLE 14.2.1.1.2.1",
      "title": "SUMMARY OF DISEASE STATUS BY ANALYSIS VISIT - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_dstatus"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.1.1.1",
      "no": "TABLE 14.2.1.1.1.1",
      "title": "OVERVIEW OF PRIMARY AND KEY SECONDARY ENDPOINTS - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_endp"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.1.2.3",
      "no": "TABLE 14.2.1.1.2.3",
      "title": "PROPORTION OF PARTICIPANTS WHO ACHIEVED CROFF AT WEEK 36: COCHRAN-MANTEL-HAENSZEL - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_croff_prop_cmh"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.1.2.4",
      "no": "TABLE 14.2.1.1.2.4",
      "title": "PROPORTION OF PARTICIPANTS WHO ACHIEVED CROFF AT WEEK 36: COCHRAN-MANTEL-HAENSZEL - PP",
      "population": "PER PROTOCOL",
      "program": "t_croff_prop_cmh"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.1.2.5",
      "no": "TABLE 14.2.1.1.2.5",
      "title": "PROPORTION OF PARTICIPANTS WHO ACHIEVED CROFF AT WEEK 36: LOGISTIC REGRESSION - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_croff_prop_lr"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.1.2.6",
      "no": "TABLE 14.2.1.1.2.6",
      "title": "PROPORTION OF PARTICIPANTS WHO ACHIEVED CROFF AT WEEK 36: MI - COCHRAN-MANTEL-HAENSZEL - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_croff_prop_mi_cmh"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.1.1",
      "no": "TABLE 14.2.1.2.1.1",
      "title": "NCOD: DESCRIPTIVE STATISTICS - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_ncodstats"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.1.2",
      "no": "TABLE 14.2.1.2.1.2",
      "title": "NCOD: ANCOVA - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_ncodancova"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.1.3",
      "no": "TABLE 14.2.1.2.1.3",
      "title": "NCOD: DESCRIPTIVE STATISTICS - PP",
      "population": "PER PROTOCOL",
      "program": "t_ncodstats"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.1.4",
      "no": "TABLE 14.2.1.2.1.4",
      "title": "NCOD: ANCOVA - PP",
      "population": "PER PROTOCOL",
      "program": "t_ncodancova"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.1.5",
      "no": "TABLE 14.2.1.2.1.5",
      "title": "NCOD: DESCRIPTIVE STATISTICS - SUPPLEMENTARY ANALYSIS - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_ncodstats"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.1.6",
      "no": "TABLE 14.2.1.2.1.6",
      "title": "NCOD: ANCOVA - SUPPLEMENTARY ANALYSIS - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_ncodancova"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.2.1",
      "no": "TABLE 14.2.1.2.2.1",
      "title": "IGA-BP: TABULATION - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_igabp"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.2.2",
      "no": "TABLE 14.2.1.2.2.2",
      "title": "PROPORTION OF PARTICIPANTS WHO ACHIEVED IGA-BP SCORE OF 0 AT WEEK 36: COCHRAN-MANTEL-HAENSZEL - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_croff_prop_cmh"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.2.4",
      "no": "TABLE 14.2.1.2.2.4",
      "title": "PROPORTION OF PARTICIPANTS WHO ACHIEVED IGA-BP SCORE OF 0 AT WEEK 36: COCHRAN-MANTEL-HAENSZEL - PP",
      "population": "PER PROTOCOL",
      "program": "t_croff_prop_cmh"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.3.1",
      "no": "TABLE 14.2.1.2.3.1",
      "title": "PROPORTION OF PARTICIPANTS WHO ACHIEVED CDA AND REMAIN FREE OF RELAPSE THROUGH WEEK 36: COCHRAN-MANTEL-HAENSZEL - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_croff_prop_cmh"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.3.2",
      "no": "TABLE 14.2.1.2.3.2",
      "title": "PROPORTION OF PARTICIPANTS WHO ACHIEVED CDA AND REMAIN FREE OF RELAPSE THROUGH WEEK 36: COCHRAN-MANTEL-HAENSZEL - PP",
      "population": "PER PROTOCOL",
      "program": "t_croff_prop_cmh"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.4.1",
      "no": "TABLE 14.2.1.2.4.1",
      "title": "PROPORTION OF PARTICIPANTS WHO ACHIEVED CRMIN AT WEEK 36: COCHRAN-MANTEL-HAENSZEL - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_croff_prop_cmh"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.4.2",
      "no": "TABLE 14.2.1.2.4.2",
      "title": "PROPORTION OF PARTICIPANTS WHO ACHIEVED CRMIN AT WEEK 36: COCHRAN-MANTEL-HAENSZEL - PP",
      "population": "PER PROTOCOL",
      "program": "t_croff_prop_cmh"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.5.1",
      "no": "TABLE 14.2.1.2.5.1",
      "title": "ITCH NRS 24-HOUR AVERAGE SCORE: DESCRIPTIVE STATISTICS OF ACTUAL VALUES AND CHANGES FROM BASELINE BY VISIT - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_baseline4"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.5.2",
      "no": "TABLE 14.2.1.2.5.2",
      "title": "ITCH NRS 24-HOUR AVERAGE SCORE: MMRM ON CHANGES FROM BASELINE - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_mmrm"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.2.5.3",
      "no": "TABLE 14.2.1.2.5.3",
      "title": "ITCH NRS 24-HOUR AVERAGE SCORE: DESCRIPTIVE STATISTICS OF ACTUAL VALUES AND CHANGES FROM BASELINE BY VISIT - PP",
      "population": "PER PROTOCOL",
      "program": "t_baseline1"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.2.1",
      "no": "TABLE 14.2.1.3.2.1",
      "title": "BPDAI ACTIVITY SCORE: DESCRIPTIVE STATISTICS OF ACTUAL VALUES, CHANGES FROM BASELINE AND PERCENT CHANGES FROM BASELINE BY VISIT - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_baseline3"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.2.2",
      "no": "TABLE 14.2.1.3.2.2",
      "title": "BPDAI ACTIVITY SCORE: MMRM ON CHANGES FROM BASELINE - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_mmrm"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.2.3",
      "no": "TABLE 14.2.1.3.2.3",
      "title": "BPDAI TOTAL SCORE: DESCRIPTIVE STATISTICS OF ACTUAL VALUES, CHANGES FROM BASELINE AND PERCENT CHANGES FROM BASELINE BY VISIT - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_baseline2"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.2.4",
      "no": "TABLE 14.2.1.3.2.4",
      "title": "BPDAI TOTAL SCORE: MMRM ON CHANGES FROM BASELINE - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_mmrm"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.3.1",
      "no": "TABLE 14.2.1.3.3.1",
      "title": "TIME TO CDA: DESCRIPTIVE STATISTICS - GEHAN-WILCOXON TEST - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_time"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.3.2",
      "no": "TABLE 14.2.1.3.3.2",
      "title": "TIME TO CR: DESCRIPTIVE STATISTICS - GEHAN-WILCOXON TEST - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_time"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.3.3",
      "no": "TABLE 14.2.1.3.3.3",
      "title": "TIME TO CRMIN: DESCRIPTIVE STATISTICS - LOGRANK TEST - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_time_logr"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.3.4",
      "no": "TABLE 14.2.1.3.3.4",
      "title": "TIME TO CR/PROFF: DESCRIPTIVE STATISTICS - LOGRANK TEST - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_time_logr"
    },
    {
      "type": "Table",
      "num": "T14.2.1.3.3.5",
      "no": "TABLE 14.2.1.3.3.5",
      "title": "Time to CRoff: Descriptive Statistics - Logrank Test - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_time_logr"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.3.6",
      "no": "TABLE 14.2.1.3.3.6",
      "title": "TIME FROM CDA ONSET TO RELAPSE: DESCRIPTIVE STATISTICS - LOGRANK TEST - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_time_logr"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.3.7",
      "no": "TABLE 14.2.1.3.3.7",
      "title": "TIME FROM CR ONSET TO RELAPSE: DESCRIPTIVE STATISTICS - LOGRANK TEST - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_time_logr"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.3.8",
      "no": "TABLE 14.2.1.3.3.8",
      "title": "TIME FROM CROFF ONSET TO RELAPSE: DESCRIPTIVE STATISTICS - LOGRANK TEST - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_time_logr"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.5.1",
      "no": "TABLE 14.2.1.3.5.1",
      "title": "ITCH NRS 24-HOUR WORST SCORE: DESCRIPTIVE STATISTICS OF ACTUAL VALUES AND CHANGES FROM BASELINE BY VISIT - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_baseline4"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.5.2",
      "no": "TABLE 14.2.1.3.5.2",
      "title": "ITCH NRS 24-HOUR WORST SCORE: MMRM ON CHANGES FROM BASELINE - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_mmrm"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.7.1",
      "no": "TABLE 14.2.1.3.7.1",
      "title": "C-GTI: DESCRIPTIVE STATISTICS OF CWS AND AIS - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_cgtistats"
    },
    {
      "section": "Efficacy",
      "type": "Table",
      "num": "T14.2.1.3.7.2",
      "no": "TABLE 14.2.1.3.7.2",
      "title": "C-GTI: ANCOVA ON CWS AND AIS - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_cgtiancova"
    },
    {
      "type": "Table",
      "num": "T14.2.1.4.1.3",
      "no": "TABLE 14.2.1.4.1.3",
      "title": "ABQOL: MMRM ON CHANGES FROM BASELINE IN ABQOL TOTAL SCORE - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_mmrm"
    },
    {
      "type": "Table",
      "num": "T14.2.1.4.2.3",
      "no": "TABLE 14.2.1.4.2.3",
      "title": "EQ-5D-5L: MMRM ON CHANGES FROM BASELINE IN VAS SCORE - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_mmrm"
    },
    {
      "type": "Table",
      "num": "T14.2.1.4.3.3",
      "no": "TABLE 14.2.1.4.3.3",
      "title": "DLQI: MMRM ON CHANGES FROM BASELINE IN DLQI SCORE - FAS  ",
      "population": "FULL ANALYSIS SET",
      "program": "t_mmrm"
    },
    {
      "section": "Pharmacodynamics",
      "type": "Table",
      "num": "T14.2.3.1",
      "no": "TABLE 14.2.3.1",
      "title": "DESCRIPTIVE STATISTICS OF ACTUAL VALUES, CHANGES FROM BASELINE AND PERCENT CHANGES FROM BASELINE IN TOTAL IGG LEVEL BY VISIT",
      "population": "PD",
      "program": "t_baseline5"
    },
    {
      "section": "Pharmacodynamics",
      "type": "Table",
      "num": "T14.2.3.5",
      "no": "TABLE 14.2.3.5",
      "title": "DESCRIPTIVE STATISTICS OF ACTUAL VALUES, CHANGES FROM BASELINE AND PERCENT CHANGES FROM BASELINE IN ANTI-BP180 AND ANTI-BP230 ANTIBODIES BY VISIT",
      "population": "PD",
      "program": "t_baseline5"
    },
    {
      "section": "Adverse Events",
      "type": "Table",
      "num": "T14.3.1.1",
      "no": "TABLE 14.3.1.1",
      "title": "ADVERSE EVENTS OVERVIEW",
      "population": "SAFETY",
      "program": "t_ae"
    },
    {
      "section": "Adverse Events",
      "type": "Table",
      "num": "T14.3.1.2",
      "no": "TABLE 14.3.1.2",
      "title": "TREATMENT-EMERGENT AND POST-TREATMENT-EMERGENT ADVERSE EVENTS BY MEDDRA SYSTEM ORGAN CLASS AND PREFERRED TERM",
      "population": "SAFETY",
      "program": "t_aesocpt2"
    },
    {
      "section": "Adverse Events",
      "type": "Table",
      "num": "T14.3.1.4",
      "no": "TABLE 14.3.1.4",
      "title": "SERIOUS TREATMENT-EMERGENT ADVERSE EVENTS BY MEDDRA SYSTEM ORGAN CLASS AND PREFERRED TERM",
      "population": "SAFETY",
      "program": "t_aesocpt4"
    },
    {
      "section": "Adverse Events",
      "type": "Table",
      "num": "T14.3.1.7",
      "no": "TABLE 14.3.1.7",
      "title": "GRADE 3 OR MORE TREATMENT-EMERGENT ADVERSE EVENTS BY MEDDRA SYSTEM ORGAN CLASS AND PREFERRED TERM",
      "population": "SAFETY",
      "program": "t_aesocpt4"
    },
    {
      "section": "Adverse Events",
      "type": "Table",
      "num": "T14.3.1.11",
      "no": "TABLE 14.3.1.11",
      "title": "TREATMENT-EMERGENT ADVERSE EVENTS LEADING TO DISCONTINUATION OF IMP BY MEDDRA SYSTEM ORGAN CLASS AND PREFERRED TERM",
      "population": "SAFETY",
      "program": "t_aesocpt4"
    },
    {
      "section": "Adverse Events",
      "type": "Table",
      "num": "T14.3.1.12",
      "no": "TABLE 14.3.1.12",
      "title": "TREATMENT-EMERGENT ADVERSE EVENTS OF SPECIAL INTEREST BY MEDDRA SYSTEM ORGAN CLASS AND PREFERRED TERM",
      "population": "SAFETY",
      "program": "t_aesocpt4"
    },
    {
      "section": "Adverse Events",
      "type": "Table",
      "num": "T14.3.1.14",
      "no": "TABLE 14.3.1.14",
      "title": "TREATMENT-EMERGENT INJECTION-RELATED REACTIONS BY MEDDRA SYSTEM ORGAN CLASS AND PREFERRED TERM",
      "population": "SAFETY",
      "program": "t_aesocpt4"
    },
    {
      "section": "Adverse Events",
      "type": "Table",
      "num": "T14.3.1.15",
      "no": "TABLE 14.3.1.15",
      "title": "SERIOUS TREATMENT-EMERGENT INJECTION-RELATED REACTIONS BY MEDDRA SYSTEM ORGAN CLASS AND PREFERRED TERM",
      "population": "SAFETY",
      "program": "t_aesocpt4"
    },
    {
      "section": "Adverse Events",
      "type": "Table",
      "num": "T14.3.1.16.1",
      "no": "TABLE 14.3.1.16.1",
      "title": "TREATMENT-EMERGENT INJECTION SITE REACTIONS - OVERVIEW",
      "population": "SAFETY",
      "program": "t_ae_isr"
    },
    {
      "section": "Adverse Events",
      "type": "Table",
      "num": "T14.3.1.16.2",
      "no": "TABLE 14.3.1.16.2",
      "title": "TREATMENT-EMERGENT INJECTION SITE REACTIONS BY MEDDRA SYSTEM ORGAN CLASS AND PREFERRED TERM",
      "population": "SAFETY",
      "program": "t_aesocpt4"
    },
    {
      "section": "Adverse Events",
      "type": "Table",
      "num": "T14.3.1.17",
      "no": "TABLE 14.3.1.17",
      "title": "FATAL TREATMENT-EMERGENT ADVERSE EVENTS BY MEDDRA SYSTEM ORGAN CLASS AND PREFERRED TERM",
      "population": "SAFETY",
      "program": "t_aesocpt4"
    },
    {
      "section": "Laboratory ",
      "type": "Table",
      "num": "T14.3.2.2",
      "no": "TABLE 14.3.2.2",
      "title": "DESCRIPTIVE STATISTICS OF ALBUMIN AND LOW-DENSITY LIPOPROTEIN-CHOLESTEROL (LDL-C) ACTUAL VALUES, CHANGES FROM BASELINE AND PERCENT CHANGES FROM BASELINE",
      "population": "SAFETY",
      "program": "t_lbchg"
    },
    {
      "section": "ECG",
      "type": "Table",
      "num": "T14.3.4.4",
      "no": "TABLE 14.3.4.4",
      "title": "TABULATION OF QTCF AND QTCB CHANGE ABNORMALITIES OVER TIME",
      "population": "SAFETY",
      "program": "t_qtctab"
    },
    {
      "section": "Adverse Events",
      "type": "Table",
      "num": "T14.2.1.3.4.1",
      "no": "TABLE 14.2.1.3.4.1",
      "title": "NCOD by Subperiod: Descriptive Statistics - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_ncodstats_sub1"
    },
    {
      "section": "Laboratory ",
      "type": "Table",
      "num": "T14.2.1.3.4.2",
      "no": "TABLE 14.2.1.3.4.2",
      "title": "NCOD by Subperiod: ANCOVA - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_ncodancova_sub1"
    },
    {
      "section": "ECG",
      "type": "Table",
      "num": "T 14.2.1.3.4.3",
      "no": "TABLE 14.2.1.3.4.3",
      "title": "COD over on IMP Treatment Period and by Subperiod: Descriptive Statistics - FAS",
      "population": "FULL ANALYSIS SET",
      "program": "t_ncodstats_sub2"
    }
  ]
}
